Finance

Lists
2796:TYO
Pharmarise Holdings Corp
506,00 JPY
-0,59%
(-3,00) 1D
8 ოქტ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2796...
Open
510 JPY
High
510 JPY
Low
505 JPY
Mkt. cap
6,13 მლრდ.
Avg. vol.
8,00 ათ.
Volume
4,60 ათ.
P/E ratio
80,87
52-wk high
554 JPY
52-wk low
471 JPY
EPS
6 JPY
Shares outstanding
9,24 მლნ.
No. of employees
2 ათ.
Open
510 JPY
High
510 JPY
Low
505 JPY
Mkt. cap
6,13 მლრდ.
Avg. vol.
8,00 ათ.
Volume
4,60 ათ.
P/E ratio
80,87
52-wk high
554 JPY
52-wk low
471 JPY
EPS
6 JPY
Shares outstanding
9,24 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
About Pharmarise Holdings Corp
CEOToshimichi Ohno
Employees2,03 ათ.
Founded28 ივნ. 1984
Headquarters-
SectorDrug
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
ნოე. 2025
თებ. 2026
მაი. 2026
აგვ. 2026
Revenue
16,85 მლრდ.
16,95 მლრდ.
18,96 მლრდ.
17,24 მლრდ.
Cost of goods sold
14,53 მლრდ.
14,60 მლრდ.
16,41 მლრდ.
15,01 მლრდ.
Cost of revenue
14,53 მლრდ.
14,60 მლრდ.
16,41 მლრდ.
15,01 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,08 მლრდ.
2,17 მლრდ.
-1,88 მლრდ.
2,17 მლრდ.
Operating expense
2,05 მლრდ.
2,20 მლრდ.
2,13 მლრდ.
2,17 მლრდ.
Total operating expenses
16,58 მლრდ.
16,80 მლრდ.
18,53 მლრდ.
17,18 მლრდ.
Operating income
273,00 მლნ.
159,00 მლნ.
422,00 მლნ.
62,00 მლნ.
Other non operating income
25,00 მლნ.
-30,00 მლნ.
-8,00 მლნ.
106,00 მლნ.
EBT including unusual items
236,00 მლნ.
67,00 მლნ.
264,00 მლნ.
80,00 მლნ.
EBT excluding unusual items
239,00 მლნ.
64,00 მლნ.
324,00 მლნ.
79,00 მლნ.
Income tax expense
108,00 მლნ.
193,00 მლნ.
137,00 მლნ.
117,00 მლნ.
Effective tax rate
45,76%
-
51,89%
146,25%
Other operating expenses
-
-
3,21 მლრდ.
-
Net income
129,00 მლნ.
-124,00 მლნ.
127,00 მლნ.
-36,00 მლნ.
Net profit margin
0,77%
-
0,67%
-0,21%
Earnings per share
-
-
-
-
Interest and investment income
3,00 მლნ.
4,00 მლნ.
3,00 მლნ.
6,00 მლნ.
Interest expense
-62,00 მლნ.
-69,00 მლნ.
-93,00 მლნ.
-95,00 მლნ.
Net interest expenses
-59,00 მლნ.
-65,00 მლნ.
-90,00 მლნ.
-89,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
656,00 მლნ.
532,25 მლნ.
823,25 მლნ.
463,25 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები